Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Cell/Gene Tx channel feed
Gene therapy biotech SpliceBio gets $135M shortly after starting first clinical trial
4 days ago
Financing
Startups
Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March
4 days ago
People
Pharma
FDA's Makary looks at ways to speed drug approvals, talks about cutting user fees
Last week
FDA+
Trump's health appointees pledge support for cell and gene therapies at FDA roundtable
Last week
FDA+
Regenxbio says Duchenne gene therapy improved motor skills in five patients
Last week
R&D
In a first, Sarepta announces platform technology designation for gene therapy vector
Last week
FDA+
At ASCO, cell therapies for deadly form of brain cancer make early strides
Last week
R&D
Immatics reports more early-stage data for melanoma cell therapy with pivotal trial underway
3 weeks ago
R&D
Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA
3 weeks ago
FDA+
CRISPR Therapeutics partners with siRNA company, showing that gene editing isn’t the only answer
4 weeks ago
R&D
Retro Biosciences inks blood disorder deal as Sam Altman-backed biotech seeks $1B in funds
4 weeks ago
Startups
Deals
Prime Medicine sidelines only clinical program, replaces CEO and lays off some staff
4 weeks ago
People
R&D
Intellia's CRISPR therapy likely causes 'permanent' gene knockdown in ATTR amyloidosis
4 weeks ago
R&D
Pharma
David Liu, Sam Sternberg unveil new way to insert big genes in human cells
4 weeks ago
R&D
Lower attendance at cell and gene therapy conference mirrors challenged industry
5 weeks ago
R&D
In three patients, Rocket’s second heart gene therapy shows promise
5 weeks ago
R&D
Eli Lilly turns to South Korean RNA editing biotech for hearing loss in deal worth $1.3B
5 weeks ago
Startups
Deals
The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease
5 weeks ago
R&D
In Focus
Advocacy groups and experts call for decade-long ban on germline editing
Last month
R&D
CRISPR patent spat revived by federal appeals court ruling
Last month
Law
Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early
Last month
People
Exclusive: Patrick Hsu startup launches, looks beyond CRISPR for gene insertion technology
Last month
Startups
'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis
Last month
R&D
In Focus
CRISPR Therapeutics' gene editing therapy reduces bad cholesterol and triglycerides by as much as 80%
Last month
R&D
1
2
3
4
Next page
Last page